Literature DB >> 26552735

Impact of Continuous Positive Airway Pressure Therapy on Atrial Electromechanical Delay in Obesity-Hypoventilation Syndrome Patients.

Vincenzo Russo1, Federica Di Meo1, Anna Rago1, Marco Mosella2, Antonio Molino2, Maria Giovanna Russo1, Gerardo Nigro1.   

Abstract

BACKGROUND: Obesity-hypoventilation syndrome (OHS) is defined as daytime hypercapnia and hypoxemia in obese patients with sleep-disordered breathing. We evaluated the electrocardiographic P-wave duration and dispersion (PD) and echocardiographic noninvasive indicators of atrial conduction heterogeneity in OHS patients and the impact of CPAP on atrial conduction and atrial fibrillation incidence. METHODS AND
RESULTS: We enrolled 50 OHS patients and 50 sex- and age-matched obese subjects as control. Study population underwent cardiologic evaluation and polysomnography before enrollment, at 1- and 6-month follow-ups after CPAP therapy. The OHS group showed a significant increase in inter-atrial (35.2 ± 8 milliseconds vs. 20.1 ± 2.7 milliseconds, P < 0.0001), intra-left (30.5 ± 7.2 milliseconds vs. 16.5 ± 2 milliseconds, P < 0.0001), and intra-right atrial electromechanical delays (AEMD)(24.8 ± 10 milliseconds vs. 15 ± 2.6 milliseconds, P < 0.0001) as well as in Pmax (130 ± 7.4 milliseconds vs. 97 ± 7.2 milliseconds, P = 0.002) and PD (56.5 ± 8.5 milliseconds vs. 31 ± 7.2 milliseconds, P = 0.002) compared to the control group. Significant improvement was noted after 6 months of CPAP therapy in inter-atrial (35.2 ± 8 milliseconds vs. 24.5 ± 6.3 milliseconds, P < 0.0001), intra-left (30.5 ± 7.2 milliseconds vs. 20.6 ± 5 milliseconds, P = 0.003), and intra-right AEMD (24.8 ± 10 milliseconds vs. 17 ± 7.5 milliseconds, P < 0.0001), as well as in Pmax (130 ± 7.4 milliseconds vs. 95 ± 10 milliseconds, P < 0.0001) and in PD (56.5 ± 8.5 milliseconds vs. 32.5 ± 6 milliseconds, P < 0.0001) in the OHS group. External loop recorder monitoring detected paroxysmal AF in 19 OHS patients (38%) with significant reduction in paroxysmal AF episodes (12 ± 6 vs. 47 ± 12, P < 0.0001) after 6-month CPAP therapy.
CONCLUSION: Our findings showed a significant increase of electrocardiographic and echocardiographic indexes of atrial conduction heterogeneity in OHS patients. The CPAP therapy, having a positive impact on atrial conduction time, seems to reduce AF incidence in OHS patients.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  CPAP therapy; P-wave dispersion; atrial electromechanic delays; obesity hypoventilation syndrome

Mesh:

Year:  2015        PMID: 26552735     DOI: 10.1111/jce.12879

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  11 in total

1.  Usefulness of the external loop recorder in a patient with Myotonic Dystrophy type 1 and recurrent episodes of palpitations: evaluation of the follow-up from diagnosis to 6 month-post-cardiac interventional treatment.

Authors:  Anna Rago; Andrea Antonio Papa; Dario Galante; Antonio Cassese; Paolo Golino
Journal:  Acta Myol       Date:  2018-05-01

2.  The role of the atrial electromechanical delay in predicting atrial fibrillation in beta-thalassemia major patients.

Authors:  Anna Rago; Vincenzo Russo; Andrea Antonio Papa; Carmine Ciardiello; Bruno Pannone; Maria Carolina Mayer; Giovanni Cimmino; Gerardo Nigro
Journal:  J Interv Card Electrophysiol       Date:  2016-11-22       Impact factor: 1.900

3.  Increased P-wave dispersion in patients with obstructive sleep apnea syndrome: a meta-analysis.

Authors:  Igor A Kelmanson
Journal:  Sleep Breath       Date:  2022-04-30       Impact factor: 2.816

4.  Complete resolution of left atrial appendage thrombosis with oral dabigatran etexilate in a patient with Myotonic Dystrophy type 1 and atrial fibrillation.

Authors:  Anna Rago; Andrea Antonio Papa; Giulia Arena; Marco Mosella; Antonio Cassese; Alberto Palladino; Paolo Golino
Journal:  Acta Myol       Date:  2017-12-01

5.  Bachmann bundle pacing reduces atrial electromechanical delay in type 1 myotonic dystrophy patients.

Authors:  Vincenzo Russo; Anna Rago; Andrea Antonio Papa; Giulia Arena; Luisa Politano; Gerardo Nigro
Journal:  J Interv Card Electrophysiol       Date:  2018-02-27       Impact factor: 1.900

6.  Increased heterogeneity of ventricular repolarization in myotonic dystrophy type 1 population.

Authors:  Vincenzo Russo; Andrea Antonio Papa; Anna Rago; Paola D'Ambrosio; Giovanni Cimmino; Alberto Palladino; Luisa Politano; Gerardo Nigro
Journal:  Acta Myol       Date:  2016-10

7.  Voltage-directed cavo-tricuspid isthmus ablation using a novel ablation catheter mapping technology in a myotonic dystrophy type I patient.

Authors:  Vincenzo Russo; Anna Rago; Andrea Antonio Papa; Federica Di Meo; Carmine Ciardiello; Giovanni Cimmino; Gerardo Nigro
Journal:  Acta Myol       Date:  2016-10

8.  The role of P-wave dispersion in dystrophic and thalassemic cardiomyopathy.

Authors:  Vincenzo Russo; Andrea A Papa; Gerardo Nigro
Journal:  JRSM Cardiovasc Dis       Date:  2017-08-01

9.  Evaluation and Management of Obesity Hypoventilation Syndrome. An Official American Thoracic Society Clinical Practice Guideline.

Authors:  Babak Mokhlesi; Juan Fernando Masa; Jan L Brozek; Indira Gurubhagavatula; Patrick B Murphy; Amanda J Piper; Aiman Tulaimat; Majid Afshar; Jay S Balachandran; Raed A Dweik; Ronald R Grunstein; Nicholas Hart; Roop Kaw; Geraldo Lorenzi-Filho; Sushmita Pamidi; Bhakti K Patel; Susheel P Patil; Jean Louis Pépin; Israa Soghier; Maximiliano Tamae Kakazu; Mihaela Teodorescu
Journal:  Am J Respir Crit Care Med       Date:  2019-08-01       Impact factor: 21.405

10.  Evaluation of Atrial Electromechanical Delay to Predict Atrial Fibrillation in Hemodialysis Patients.

Authors:  Hakan Gunes; Abdullah Sokmen; Hakki Kaya; Ozkan Gungor; Murat Kerkutluoglu; Fatma Betul Guzel; Gulizar Sokmen
Journal:  Medicina (Kaunas)       Date:  2018-08-25       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.